Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a revision label updated from v3.6.0 to v3.6.3, indicating a recent update to the page framework. This change is an internal maintenance update and does not modify the study information presented.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a recruitment-status note indicating that the study is no longer enrolling participants.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, reflecting a minor metadata update rather than substantive changes to study details.SummaryDifference0.0%

- Check55 days agoChange DetectedA new page revision tag, v3.5.4, was added and the previous v3.5.3 tag was removed, indicating a minor version update.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, reflecting a site release/update rather than any change to the study record details.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated to v3.5.2; revision v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.